Elimination of Harsh Chemicals
The bioconversion process replaces strong mineral acids with mild enzymatic reactions, reducing corrosion and waste.
Levulinic Acid LA is a versatile platform chemical identified by the US Department of Energy as one of the top bio-based building blocks. It is primarily used as a precursor for Bio-monomers/Plasticizers, fuel additives, and solvents. Its traditional production faces significant limitations: Chemical conversion from cellulose/glucose is low-yield and requires harsh acid/heat conditions. This results in high energy consumption and corrosive waste streams.
CD Biosynsis offers two advanced biological routes to circumvent these issues: Bioconversion: Use engineered microbes e.g., Pseudomonas putida to oxidize cheap HMF or Furfural into LA. This utilizes existing bio-derived intermediates under mild conditions. Additionally, we use Genetic Engineering: Design a synthetic LA pathway starting from L-threonine. This highly efficient de novo pathway provides a direct, fermentation-based route from simple sugars to LA, ensuring high purity and yield.
Get a QuoteThe traditional thermo-chemical production of Levulinic Acid LA presents these major drawbacks:
A sustainable solution requires a transition to mild, highly specific enzymatic or microbial conversion processes.
CD Biosynsis employs metabolic and genetic engineering to establish highly efficient LA production:
Bioconversion of HMF Furfural
We engineer Pseudomonas putida or E. coli to efficiently oxidize platform intermediates HMF or Furfural into LA under ambient conditions.
De Novo Pathway Design from L-Threonine
We design a synthetic metabolic pathway starting from the amino acid L-threonine to produce LA, eliminating the need for hydrolysis intermediates.
Enzyme Pathway Optimization
We screen and optimize non-native enzymes e.g. dehydratases, transferases to construct an efficient and selective LA biosynthesis route with minimal side product formation.
Robust Host Strain Development
We develop host strains with tolerance to acid products and feedstock inhibitors like Furfural, ensuring high yield in industrial media.
These biological routes replace harsh chemistry with mild, selective enzymatic catalysis, yielding purer LA at lower cost.
Our Levulinic Acid LA engineering service offers these core benefits:
Elimination of Harsh Chemicals
The bioconversion process replaces strong mineral acids with mild enzymatic reactions, reducing corrosion and waste.
High Selectivity and Purity Icon
Enzymatic specificity dramatically reduces undesired byproducts e.g. humins, simplifying downstream purification.
De Novo Pathway Flexibility
The L-Threonine route allows for direct fermentation from simple sugars to LA, bypassing chemical hydrolysis altogether.
Cost-Effective Feedstock Utilization
Engineered strains can utilize lignocellulosic sugar intermediates which are cheaper than purified glucose.
Mild Operating Conditions
The microbial process runs at ambient or moderate temperatures, drastically lowering energy demand compared to thermo-chemical routes.
We deliver a truly green and economically viable solution for LA production.
Our Levulinic Acid LA engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a sustainable, high-purity Levulinic Acid supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is the chemical conversion of cellulose to LA so inefficient?
The process involves multiple acid-catalyzed steps including cellulose hydrolysis to glucose, then glucose dehydration to HMF, and finally HMF hydrolysis to LA. Each step generates significant unwanted side products e.g. humins, which polymerize and trap intermediate molecules, drastically reducing the final LA yield.
What is the advantage of the L-Threonine synthetic pathway?
The L-Threonine pathway is a de novo biosynthesis route that allows the microbe to produce LA directly from a simple carbon source e.g. glucose without passing through the HMF or Furfural intermediates. This high-specificity enzymatic route eliminates the side reaction issues of chemical conversion, leading to higher purity and yield.
Why use Pseudomonas putida for bioconversion?
P. putida is naturally robust and known for its high tolerance to solvents and toxic aromatic compounds e.g. Furfural. This makes it an ideal host to process the toxic intermediate feedstocks derived from lignocellulosic biomass hydrolysis without suffering severe growth inhibition.
What are Bio-monomers/Plasticizers derived from LA?
LA can be easily hydrogenated to gamma-Valerolactone GVL, which is a widely used green solvent. It is also used to synthesize various polyester monomers and plasticizers such as Methyltetrahydrofuran MTHF and poly}\text{levulinates, providing sustainable alternatives to petroleum-based polymers.
What is the estimated project timeline?
A comprehensive project involving synthetic pathway design, strain engineering, and fermentation optimization typically requires 35-45 weeks for final strain delivery and validated LA production protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.